Erratum to: Ultra–low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma (Head Neck, (2017), 39, (1095–1100), 10.1002/hed.24717)

Chelsea C. Pinnix, Bouthaina S. Dabaja, Sarah A Milgrom, Grace L. Smith, Zeinab Abou, Loretta Nastoupil, Jorge E Romaguera, Francesco Turturro, Nathan Fowler, Luis Fayad, Jason Westin, Sattva Neelapu, Michelle A Fanale, Maria A. Rodriguez, Fredrick B Hagemeister, Hun Ju Lee, Yasuhiro Oki, Michael Wang, Felipe Samaniego, Linda ChiBita Esmaeli

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations

Abstract

The authors have brought to our attention that an incorrect panel B was supplied for Figure. A corrected Figure, panels A-D, appears below. The authors apologize for their error. (Figure presented.) Complete response to ultra–low-dose orbital radiotherapy (RT) for mantle cell lymphoma (MCL) achieved 10 months after completion of RT. (A) A 70-year-old woman with stage IV MCL had a dominant enhancing left lacrimal gland mass measuring 2.631.5 cm on axial postcontrast CT imaging. (B) She was treated with 4 Gy in 2 fractions with 16-MeV electrons. (C) She had a partial response to RT at 4 months after completion of RT. (D) She had a complete response to RT at 10.5 months after completion of RT without any interval treatment [Color figure can be viewed at wileyonlinelibrary.com].

Original languageEnglish (US)
Pages (from-to)1335
Number of pages1
JournalHead and Neck
Volume40
Issue number6
DOIs
StatePublished - Jun 2018

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint

Dive into the research topics of 'Erratum to: Ultra–low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma (Head Neck, (2017), 39, (1095–1100), 10.1002/hed.24717)'. Together they form a unique fingerprint.

Cite this